Hepatitis  >>  MBL-HCV1  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MBL-HCV1 / MassBiologics
NCT01121185: Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

Terminated
2
13
US
MBL-HCV1, 0.9% Sodium chloride Placebo, Normal Saline
MassBiologics
HCV Infection, Liver Transplantation
06/11
06/11

Download Options